Tarriff Scott
CIK 0001469124 Name as filed on the most recent filing
Filed as Tarriff Scott (18)
54 transaction lines · from 18 filings · filed 2015-07-02 to 2023-11-03 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
54 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2023-11-02 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 10,694 disposed | 13.87 | 148,325.78 | Form 4, filing 0001209191-23-054333 | |
| 2023-11-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 10,925 disposed | 13.82 | 150,983.50 | Form 4, filing 0001209191-23-054333 | |
| 2023-10-03 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 10,024 disposed | 14.41 | 144,445.84 | Form 4, filing 0001209191-23-052030 | |
| 2023-10-03 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 710 disposed | 15.11 | 10,728.10 | Form 4, filing 0001209191-23-052030 | |
| 2023-10-02 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 9,511 disposed | 15.23 | 144,852.53 | Form 4, filing 0001209191-23-052030 | |
| 2023-05-16 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 15,000 disposed | 19.98 | 299,700.00 | Form 4, filing 0001209191-23-030725 | |
| 2023-05-15 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 14,800 disposed | 21.06 | 311,688.00 | Form 4, filing 0001209191-23-029625 | |
| 2023-05-15 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 200 disposed | 21.52 | 4,304.00 | Form 4, filing 0001209191-23-029625 | |
| 2023-05-12 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 11,869 disposed | 20.42 | 242,364.98 | Form 4, filing 0001209191-23-029625 | |
| 2023-05-12 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 3,131 disposed | 19.69 | 61,649.39 | Form 4, filing 0001209191-23-029625 | |
| 2023-05-11 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 15,000 disposed | 20.71 | 310,650.00 | Form 4, filing 0001209191-23-029625 | |
| 2019-04-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 24,975 disposed | 50.15 | 1,252,496.25 | Form 4, filing 0001209191-19-023147 | |
| 2019-03-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 12,428 disposed | 51.81 | 643,894.68 | Form 4, filing 0001209191-19-015645 | |
| 2019-03-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 12,000 disposed | 50.51 | 606,120.00 | Form 4, filing 0001209191-19-015645 | |
| 2019-02-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 29,185 disposed | 41.52 | 1,211,761.20 | Form 4, filing 0001209191-19-007134 | |
| 2019-02-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 900 disposed | 42.30 | 38,070.00 | Form 4, filing 0001209191-19-007134 | |
| 2019-01-03 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 10,597 disposed | 39.04 | 413,706.88 | Form 4, filing 0001209191-19-002391 | |
| 2019-01-03 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 5,670 disposed | 39.70 | 225,099.00 | Form 4, filing 0001209191-19-002391 | |
| 2019-01-03 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 302 disposed | 40.57 | 12,252.14 | Form 4, filing 0001209191-19-002391 | |
| 2019-01-02 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 8,500 disposed | 40.03 | 340,255.00 | Form 4, filing 0001209191-19-002391 | |
| 2019-01-02 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 6,500 disposed | 39.30 | 255,450.00 | Form 4, filing 0001209191-19-002391 | |
| 2016-04-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 30,765 disposed | 40.63 | 1,249,981.95 | Form 4, filing 0001209191-16-113116 | |
| 2016-03-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 11,978 disposed | 63.52 | 760,842.56 | Form 4, filing 0001209191-16-105298 | |
| 2016-03-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 7,802 disposed | 62.70 | 489,185.40 | Form 4, filing 0001209191-16-105298 | |
| 2016-02-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 5,367 disposed | 66.03 | 354,383.01 | Form 4, filing 0001209191-16-094813 | |
| 2016-02-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 5,260 disposed | 68.52 | 360,415.20 | Form 4, filing 0001209191-16-094813 | |
| 2016-02-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 3,600 disposed | 67.46 | 242,856.00 | Form 4, filing 0001209191-16-094813 | |
| 2016-02-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 2,431 disposed | 69.95 | 170,048.45 | Form 4, filing 0001209191-16-094813 | |
| 2016-02-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 1,702 disposed | 71.84 | 122,271.68 | Form 4, filing 0001209191-16-094813 | |
| 2016-01-04 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 11,776 disposed | 85.65 | 1,008,614.40 | Form 4, filing 0001209191-16-088749 | |
| 2016-01-04 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 2,773 disposed | 87.02 | 241,306.46 | Form 4, filing 0001209191-16-088749 | |
| 2015-12-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 4,744 disposed | 87.85 | 416,760.40 | Form 4, filing 0001209191-15-082913 | |
| 2015-12-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 3,700 disposed | 90.99 | 336,663.00 | Form 4, filing 0001209191-15-082913 | |
| 2015-12-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 2,806 disposed | 86.92 | 243,897.52 | Form 4, filing 0001209191-15-082913 | |
| 2015-12-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 1,500 disposed | 88.80 | 133,200.00 | Form 4, filing 0001209191-15-082913 | |
| 2015-12-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 1,300 disposed | 91.46 | 118,898.00 | Form 4, filing 0001209191-15-082913 | |
| 2015-11-02 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 11,713 disposed | 64.07 | 750,451.91 | Form 4, filing 0001209191-15-078192 | |
| 2015-11-02 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 7,626 disposed | 65.50 | 499,503.00 | Form 4, filing 0001209191-15-078192 | |
| 2015-10-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 8,235 disposed | 69.27 | 570,438.45 | Form 4, filing 0001209191-15-073947 | |
| 2015-10-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 7,027 disposed | 70.28 | 493,857.56 | Form 4, filing 0001209191-15-073947 | |
| 2015-10-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 1,548 disposed | 72.67 | 112,493.16 | Form 4, filing 0001209191-15-073947 | |
| 2015-10-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 1,065 disposed | 68.50 | 72,952.50 | Form 4, filing 0001209191-15-073947 | |
| 2015-10-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 3 disposed | 74.36 | 223.06 | Form 4, filing 0001209191-15-073947 | |
| 2015-09-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 11,792 disposed | 76.88 | 906,568.96 | Form 4, filing 0001209191-15-069431 | |
| 2015-09-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 2,526 disposed | 77.93 | 196,851.18 | Form 4, filing 0001209191-15-069431 | |
| 2015-09-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 1,878 disposed | 76.09 | 142,897.02 | Form 4, filing 0001209191-15-069431 | |
| 2015-09-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 49 disposed | 75.12 | 3,680.88 | Form 4, filing 0001209191-15-069431 | |
| 2015-08-03 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 10,658 disposed | 96.36 | 1,027,004.88 | Form 4, filing 0001209191-15-063783 | |
| 2015-08-03 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 2,342 disposed | 95.39 | 223,403.38 | Form 4, filing 0001209191-15-063783 | |
| 2015-07-01 |
Eagle Pharmaceuticals, Inc. EGRX |
S, Open-market sale | 6,015 disposed | 78.98 | 475,064.70 | Form 4, filing 0001209191-15-058900 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 54
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Tarriff Scott, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001469124
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6